Is Visceral Fat the Missing Link in the Relationship Between Inflammation and Insulin Resistance in RA?

REFERENCES

1. 1.↵
   1. Ferraz-Amaro I,
   2. Arce-Franco M,
   3. Muniz J,
   4. Lopez-Fernandez J,
   5. Hernandez-Hernandez V,
   6. Franco A,
   7. et al.

   Systemic blockade of TNF-alpha does not improve insulin resistance in humans. Horm Metab Res 2011;43:801–8.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Ferraz-Amaro I,
   2. Garcia-Dopico JA,
   3. Medina-Vega L,
   4. Gonzalez-Gay MA,
   5. Diaz-Gonzalez F

   . Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients. Arthritis Res Ther 2013;15:R17.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Chung CP,
   2. Oeser A,
   3. Solus JF,
   4. Avalos I,
   5. Gebretsadik T,
   6. Shintani A,
   7. et al.

   Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 2008;196:756–63.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Rosenvinge A,
   2. Krogh-Madsen R,
   3. Baslund B,
   4. Pedersen BK

   . Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy. Scand J Rheumatol 2007;36:91–6.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Paolisso G,
   2. Valentini G,
   3. Giugliano D,
   4. Marrazzo G,
   5. Tirri R,
   6. Gallo M,
   7. et al.

   Evidence for peripheral impaired glucose handling in patients with connective tissue diseases. Metabolism 1991;40:902–7.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Penesova A,
   2. Radikova Z,
   3. Vlcek M,
   4. Kerlik J,
   5. Lukac J,
   6. Rovensky J,
   7. et al.

   Chronic inflammation and low-dose glucocorticoid effects on glucose metabolism in premenopausal females with rheumatoid arthritis free of conventional metabolic risk factors. Physiol Res 2013;62:75–83.

   OpenUrlPubMed
7. 7.↵
   1. Hoes JN,
   2. van der Goes MC,
   3. van Raalte DH,
   4. van der Zijl NJ,
   5. den Uyl D,
   6. Lems WF,
   7. et al.

   Glucose tolerance, insulin sensitivity and beta-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids. Ann Rheum Dis 2011;70:1887–94.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Dessein PH,
   2. Joffe BI,
   3. Stanwix A,
   4. Botha AS,
   5. Moomal Z

   . The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis. J Rheumatol 2002;29:462–6.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Toussirot E,
   2. Grandclement E,
   3. Gaugler B,
   4. Michel F,
   5. Wendling D,
   6. Saas P,
   7. et al.

   Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. A comparative study. Front Immunol 2013;4:453.

   OpenUrlPubMed
10. 10.↵
    1. Stagakis I,
    2. Bertsias G,
    3. Karvounaris S,
    4. Kavousanaki M,
    5. Virla D,
    6. Raptopoulou A,
    7. et al.

    Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance. Arthritis Res Ther 2012;14:R141.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Schultz O,
    2. Oberhauser F,
    3. Saech J,
    4. Rubbert-Roth A,
    5. Hahn M,
    6. Krone W,
    7. et al.

    Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases. PloS One 2010;5:e14328.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Feingold KR,
    2. Soued M,
    3. Staprans I,
    4. Gavin LA,
    5. Donahue ME,
    6. Huang BJ,
    7. et al.

    Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia. J Clin Invest 1989;83:1116–21.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Kim HJ,
    2. Higashimori T,
    3. Park SY,
    4. Choi H,
    5. Dong J,
    6. Kim YJ,
    7. et al.

    Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 2004;53:1060–7.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Osborn O,
    2. Olefsky JM

    . The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012;18:363–74.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. AbouAssi H,
    2. Tune KN,
    3. Gilmore B,
    4. Bateman LA,
    5. McDaniel G,
    6. Muehlbauer M,
    7. et al.

    Adipose depots, not disease-related factors, account for skeletal muscle insulin sensitivity in established and treated rheumatoid arthritis. J Rheumatol 2014;41:1974–9.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Muniyappa R,
    2. Lee S,
    3. Chen H,
    4. Quon MJ

    . Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008;294:E15–26.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Elkan AC,
    2. Hakansson N,
    3. Frostegard J,
    4. Hafstrom I

    . Low level of physical activity in women with rheumatoid arthritis is associated with cardiovascular risk factors but not with body fat mass—a cross sectional study. BMC Musculoskelet Disord 2011;12:13.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Giles JT,
    2. Ling SM,
    3. Ferrucci L,
    4. Bartlett SJ,
    5. Andersen RE,
    6. Towns M,
    7. et al.

    Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum 2008;59:807–15.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Giles JT,
    2. Allison M,
    3. Blumenthal RS,
    4. Post W,
    5. Gelber AC,
    6. Petri M,
    7. et al.

    Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum 2010;62:3173–82.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Esser N,
    2. Legrand-Poels S,
    3. Piette J,
    4. Scheen AJ,
    5. Paquot N

    . Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014; Apr 13 (E-pub ahead of print).
21. 21.↵
    1. Mauer J,
    2. Chaurasia B,
    3. Goldau J,
    4. Vogt MC,
    5. Ruud J,
    6. Nguyen KD,
    7. et al.

    Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat Immunol 2014;15:423–30.

    OpenUrlPubMed
22. 22.↵
    1. Kontny E,
    2. Prochorec-Sobieszek M

    . Articular adipose tissue resident macrophages in rheumatoid arthritis patients: potential contribution to local abnormalities. Rheumatology 2013;52:2158–67.

    OpenUrlAbstract/FREE Full Text